NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer



Studies from J. Liang et al add new findings in the area of cancer



August 28th, 2008

"The aim of this study was to evaluate the utility of Tc-99m-diethylenetriaminepentaacetic acid-deoxyglucose (DTPA-DG) for monitoring the early response of tumors to chemotherapy. To evaluate the role of Tc-99m-DTPA-DG in vitro chemotherapy, the uptake ratios assays were conducted using A549 lung cancer and MCF-7 breast cancer cells after the 2 tumor cell types had been treated with cisplatin and paclitaxel chemotherapeutic agents, respectively," researchers in Luzhou, People's Republic of China report.

"Apoptosis in the 2 cell types, an indicator of chemotherapeutic action, was assessed by inverted fluorescence microscope and flow cytometry. The assessment of...


Source: Women's Health Weekly (2008-08-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login